Results 211 to 220 of about 15,580 (252)

Long-Term Disease Control During Continuous Treatment with Upadacitinib and Baricitinib for Moderate-to-Severe Atopic Dermatitis: a Real-World Monocentric Retrospective Study. [PDF]

Dermatol Ther (Heidelb)
D'Oria F, Falcidia C, Foggi G, Bianco M, Cascio Ingurgio R, Alfano A, Ibba L, Valenti M, Costanzo A, Narcisi A, Gargiulo L.   +10 more
europepmc   +1 more source

Real-World Effectiveness and Safety of 12 Months of Tralokinumab in Patients with Atopic Dermatitis. [PDF]

Dermatol Ther (Heidelb)
Armstrong AW, Ameen A, Ferrucci S, Pereyra-Rodríguez JJ, Cork MJ, Rubin C, Jarell A, Narcisi A, Becherel PA, Beecker J, Festini T, Vittrup I, Vinther F, Thaçi D.   +13 more
europepmc   +1 more source

The Dyshidrotic Eczema Area and Severity Index – A Score Developed for the Assessment of Dyshidrotic Eczema

Dermatology, 1999
<b>Background:</b> Dyshidrotic eczema of the palms and soles is a common condition, which can be rather resistant to treatment. Therapy studies and their comparability are of clinical importance. <b>Objective:</b> As standardized assessment methods for the severity of this particular form of eczema are lacking, we developed a ...
S G Plötz, E Vocks
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

The Eczema Area and Severity Index (EASI): Assessment of Reliability in Atopic Dermatitis

Experimental Dermatology, 2001
Abstract: Objective – To test the reliability of the eczema area and severity index (EASI) scoring system by assessing inter‐ and intra‐observer consistency. Design: Training of evaluators, application, and assessment over 2 consecutive days.
Jon M Hanifin, M Graeber
exaly   +2 more sources

Use of the Self-Administered Eczema Area and Severity Index by Parent Caregivers: Results of a Validation Study

British Journal of Dermatology, 2002
The Eczema Area and Severity Index (EASI) is used by dermatological investigators world-wide to assess eczema disease severity. EASI measures are, however, time-consuming and require trained personnel, thereby limiting its application to large-scale epidemiological studies.
Steven R. Feldman, M J Patel, R Balkrishnan   +2 more
exaly   +3 more sources

What the Eczema Area and Severity Index Score Tells Us About the Severity of Atopic Dermatitis: An Interpretability Study

British Journal of Dermatology, 2015
The Eczema Area and Severity Index (EASI) is an investigator-assessed instrument measuring the severity of clinical signs in atopic dermatitis (AD). The EASI was identified as one of the best-validated outcome measures for AD; however, no previous studies address how to interpret the EASI score for clinical use.To evaluate the interpretability and the ...
Yael Anne Leshem, Eric Simpson, J M Hanifin   +2 more
exaly   +3 more sources

What Are the Best Outcome Measurements for Atopic Eczema? A Systematic Review

Journal of Allergy and Clinical Immunology, 2007
BACKGROUND: Valid and reliable outcome measurements are a prerequisite for evidence-based practice. The comparative validity and reliability of outcome measurements for assessing atopic eczema (AE) severity is unclear.
Sinead M Langan, Jochen Schmitt
exaly   +2 more sources